Advanced search
Publication Cover
OncoImmunology Volume 9, 2020 - Issue 1
Submit an article Journal homepage
1,812
Views
1
CrossRef citations to date
0
Altmetric
Other

Turning tolerogenic into immunogenic ileal cell death through ileal microbiota: the key to unlock the mystery of colon cancer immunoscore?

Maria Paula Robertia Gustave Roussy Cancer Campus (GRCC), UMR 1015, Villejuif, France;b Institut National de la Santé et de la Recherche Medicale (INSERM) U1015, Equipe Labellisée—Ligue Nationale Contre le Cancer, Villejuif, France;c Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 1428, Villejuif, FranceORCID Iconhttps://orcid.org/0000-0001-5788-6840View further author information
ORCID Icon,
Marion Picarda Gustave Roussy Cancer Campus (GRCC), UMR 1015, Villejuif, France;b Institut National de la Santé et de la Recherche Medicale (INSERM) U1015, Equipe Labellisée—Ligue Nationale Contre le Cancer, Villejuif, France;d Unit Biology and Genetics of the Bacterial Cell Wall, Institut Pasteur Paris, Paris, FranceView further author information
,
Satoru Yonekuraa Gustave Roussy Cancer Campus (GRCC), UMR 1015, Villejuif, France;b Institut National de la Santé et de la Recherche Medicale (INSERM) U1015, Equipe Labellisée—Ligue Nationale Contre le Cancer, Villejuif, France;e Université Paris-Saclay, Faculté de Médecine, Le Kremlin-Bicêtre cedex, FranceORCID Iconhttps://orcid.org/0000-0003-4047-3016View further author information
ORCID Icon &
Laurence Zitvogela Gustave Roussy Cancer Campus (GRCC), UMR 1015, Villejuif, France;b Institut National de la Santé et de la Recherche Medicale (INSERM) U1015, Equipe Labellisée—Ligue Nationale Contre le Cancer, Villejuif, France;c Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 1428, Villejuif, France;e Université Paris-Saclay, Faculté de Médecine, Le Kremlin-Bicêtre cedex, France;f Suzhou Institute for Systems Medicine, Chinese Academy of Medical Sciences, Suzhou, ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-1596-0998View further author information
ORCID Icon
Article: 1778834 | Received 27 May 2020, Accepted 30 May 2020, Published online: 14 Jun 2020

References

  • Pagès F, Mlecnik B, Marliot F, Bindea G, Ou F-S, Bifulco C, Lugli A, Zlobec I, Rau TT, Berger MD, et al. International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study. Lancet. 2018;391:2128–3. doi:10.1016/S0140-6736(18)30789-X.
  • Tesniere A, Schlemmer F, Boige V, Kepp O, Martins I, Ghiringhelli F, Aymeric L, Michaud M, Apetoh L, Barault L, et al. Immunogenic death of colon cancer cells treated with oxaliplatin. Oncogene. 2010;29:482–491. doi:10.1038/onc.2009.356.
  • Ciardiello D, Vitiello PP, Cardone C, Martini G, Troiani T, Martinelli E, Ciardiello F. Immunotherapy of colorectal cancer: challenges for therapeutic efficacy. Cancer Treat Rev. 2019;76:22–32. doi:10.1016/j.ctrv.2019.04.003.
  • Roberti MP, Yonekura S, Duong CPM, Picard M, Ferrere G, Tidjani Alou M, Rauber C, Iebba V, Lehmann CHK, Amon L, et al. Chemotherapy-induced ileal crypt apoptosis and the ileal microbiome shape immunosurveillance and prognosis of proximal colon cancer. Nat Med. 2020 May 25. (published online ahead of print). DOI:10.1038/s41591-020-0882-8.
  • Bindea G, Mlecnik B, Tosolini M, Kirilovsky A, Waldner M, Obenauf A, Angell H, Fredriksen T, Lafontaine L, Berger A, et al. Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity. 2013;39:782–795. doi:10.1016/j.immuni.2013.10.003.
  • Gu-Trantien C, Migliori E, Buisseret L, de Wind A, Brohée S, Garaud S, Noël G, C.V. LD, Lodewyckx J-N, Naveaux C, et al. CXCL13-producing TFH cells link immune suppression and adaptive memory in human breast cancer. JCI Insight. 2017;2:e91487. doi:10.1172/jci.insight.91487.
  • Garaud S, Buisseret L, Solinas C, Gu-Trantien C, de Wind A, Van den Eynden G, Naveaux C, Lodewyckx J-N, Boisson A, Duvillier H, et al. Tumor-infiltrating B cells signal functional humoral immune responses in breast cancer. JCI Insight. 2019;4:e129641. doi:10.1172/jci.insight.129641.
  • Hollern DP, Xu N, Thennavan A, Glodowski C, Garcia-Recio S, Mott KR, He X, Garay JP, Carey-Ewend K, Marron D, et al. B cells and T follicular helper cells mediate response to checkpoint inhibitors in high mutation burden mouse models of breast cancer. Cell. 2019;179:1191–1206.e21. doi:10.1016/j.cell.2019.10.028.
  • Helmink BA, Reddy SM, Gao J, Zhang S, Basar R, Thakur R, Yizhak K, Sade-Feldman M, Blando J, Han G, et al. B cells and tertiary lymphoid structures promote immunotherapy response. Nature. 2020;577:549–555. doi:10.1038/s41586-019-1922-8.
  • Cabrita R, Lauss M, Sanna A, Donia M, Skaarup Larsen M, Mitra S, Johansson I, Phung B, Harbst K, Vallon-Christersson J, et al. Tertiary lymphoid structures improve immunotherapy and survival in melanoma. Nature. 2020;577:1–5. doi:10.1038/s41586-020-2155-6.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.